🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a follow-up of the primary series vaccination schedule in Study A3L...
Status
Completed
Location
Multiple Locations
Start Date
2011-09
Trial ID
NCT01444781
To demonstrate that the immune response to hepatitis B antigen of the DTaP-...
Status
Completed
Location
Multiple Locations
Start Date
2006-07
Trial ID
NCT00315055
Treatments Being Tested
This is a follow-up of the primary series vaccination schedule in Study A3L...
Status
Completed
Location
Multiple Locations
Start Date
2013-10
Trial ID
NCT01983540
Primary Objective: 1. To describe the vaccine seroprotection (antibody tit...
Status
Completed
Location
Investigational Site Number :4840001
Start Date
2018-10-17
Trial ID
NCT03630705
Treatments Being Tested
The purpose of this study is to assess the immunogenicity and safety of ACT...
Status
Completed
Location
Multiple Locations
Start Date
2010-01
Trial ID
NCT01062477
This is a follow-up of Study A3L11 (NCT00404651). Immunogenicity * To des...
Status
Completed
Location
Multiple Locations
Start Date
2008-03
Trial ID
NCT00654901
The purpose of this study is to evaluate the safety and immunogenicity of t...
Status
Recruiting
Location
Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention
Start Date
2023-12-21
Trial ID
NCT06344065
Treatments Being Tested
Primary Series Primary objectives * To demonstrate that the concomitant ad...
Status
Completed
Location
Sanofi Pasteur MSD Investigational Site 003
Start Date
2013-04
Trial ID
NCT01839175
Treatments Being Tested
PR5I, a hexavalent pediatric combination vaccine is being developed to redu...
Status
Completed
Location
Multiple Locations
Start Date
2006-08
Trial ID
NCT00362427
This open label randomized study will be conducted to evaluate and/or descr...
Status
Completed
Location
Investigational Site Number : 3560006
Start Date
2023-03-27
Trial ID
NCT05794230
Treatments Being Tested